Bigtincan Holdings (ASX:BTH) will be owned by San Francisco-based private equity firm Vector Capital in the wake of today’s ...

Dr. Simone Steiner will focus on improving the manufacturing processes of individualized immunotherapies based on myvac® platform Strasbourg, ...

Target and Tesla, among others, have been on the receiving end of economic boycotts. At the heart of their rebuilding process ...

Akamai (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers and protects business online, today unveiled ...

LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

Progressive Web Apps, or PWAs, can turn app-like websites into website-like apps. Browsers are beefing up support for these ...

Like many of the best car logos, the Tesla logo was originally conceived to look good on the front of vehicles, which it why ...

OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: OXB) (the ...

FOXO Technologies Inc. announced a non-binding agreement to acquire Vector Biosource Inc., a provider of biospecimen sourcing in the biotech and pharmaceutical sectors, with expected revenue of $ ...

Researchers discuss a novel method to predict biological aging using a deep neural network based on pathways of ...

MINNEAPOLIS, MN, March 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), announces that it has signed a non-binding agreement to acquire Vector ...